As of 2026-03-05, the Intrinsic Value of Sedana Medical AB (publ) (SEDANA.ST) is 12.73 SEK. This SEDANA.ST valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y). With the current market price of 8.31 SEK, the upside of Sedana Medical AB (publ) is 53.20%.
The range of the Intrinsic Value is 8.85 - 18.72 SEK
Based on its market price of 8.31 SEK and our intrinsic valuation, Sedana Medical AB (publ) (SEDANA.ST) is undervalued by 53.20%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (392.57) - (16.79) | (32.17) | -487.1% |
| DCF (Growth 10y) | (19.20) - (419.60) | (35.72) | -529.8% |
| DCF (EBITDA 5y) | 8.85 - 18.72 | 12.73 | 53.2% |
| DCF (EBITDA 10y) | 5.66 - 19.76 | 10.89 | 31.0% |
| Fair Value | -2.05 - -2.05 | -2.05 | -124.62% |
| EV/EBITDA | (0.50) - 34.86 | 10.34 | 24.5% |
| EPV | (18.65) - (33.62) | (26.14) | -414.5% |
| DDM - Stable | (4.87) - (143.11) | (73.99) | -990.4% |
| DDM - Multi | (0.02) - (0.31) | (0.03) | -100.3% |
| Market Cap (mil) | 825.52 |
| Beta | 1.65 |
| Outstanding shares (mil) | 99.34 |
| Enterprise Value (mil) | 717.61 |
| Market risk premium | 5.10% |
| Cost of Equity | 6.96% |
| Cost of Debt | 5.50% |
| WACC | 6.95% |